These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells. Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827 [TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's]. Nadal-Ginard B; Torella D; Ellison G Rev Esp Cardiol; 2006 Nov; 59(11):1175-89. PubMed ID: 17144992 [TBL] [Abstract][Full Text] [Related]
5. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming. Yamakawa H; Ieda M Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939 [TBL] [Abstract][Full Text] [Related]
6. Advances in cell-based therapy for structural heart disease. Mazhari R; Hare JM Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519 [TBL] [Abstract][Full Text] [Related]
7. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Capi O; Gepstein L J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287 [TBL] [Abstract][Full Text] [Related]
8. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges. Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353 [TBL] [Abstract][Full Text] [Related]
9. microRNA and Cardiac Regeneration. Gnecchi M; Pisano F; Bariani R Adv Exp Med Biol; 2015; 887():119-41. PubMed ID: 26662989 [TBL] [Abstract][Full Text] [Related]
10. Stem cell sources for cardiac regeneration. Roccio M; Goumans MJ; Sluijter JP; Doevendans PA Panminerva Med; 2008 Mar; 50(1):19-30. PubMed ID: 18427385 [TBL] [Abstract][Full Text] [Related]
11. The bone marrow--cardiac axis of myocardial regeneration. Liao R; Pfister O; Jain M; Mouquet F Prog Cardiovasc Dis; 2007; 50(1):18-30. PubMed ID: 17631435 [TBL] [Abstract][Full Text] [Related]
12. Contemplating the bright future of stem cell therapy for cardiovascular disease. Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622 [TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. Iglesias-García O; Pelacho B; Prósper F J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470 [TBL] [Abstract][Full Text] [Related]
14. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990 [TBL] [Abstract][Full Text] [Related]
15. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf]. Schannwell CM Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806 [TBL] [Abstract][Full Text] [Related]
16. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells. Tongers J; Losordo DW J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950 [TBL] [Abstract][Full Text] [Related]
17. Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology. Hodgkinson CP; Bareja A; Gomez JA; Dzau VJ Circ Res; 2016 Jan; 118(1):95-107. PubMed ID: 26837742 [TBL] [Abstract][Full Text] [Related]